These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 35626663)

  • 1. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.
    Korfei M; Mahavadi P; Guenther A
    Cells; 2022 May; 11(10):. PubMed ID: 35626663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
    Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
    Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
    Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
    PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
    Conforti F; Davies ER; Calderwood CJ; Thatcher TH; Jones MG; Smart DE; Mahajan S; Alzetani A; Havelock T; Maher TM; Molyneaux PL; Thorley AJ; Tetley TD; Warner JA; Packham G; Ganesan A; Skipp PJ; Marshall BJ; Richeldi L; Sime PJ; O'Reilly KMA; Davies DE
    Oncotarget; 2017 Jul; 8(30):48737-48754. PubMed ID: 28467787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
    Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
    Coward WR; Watts K; Feghali-Bostwick CA; Jenkins G; Pang L
    Mol Cell Biol; 2010 Jun; 30(12):2874-86. PubMed ID: 20404089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
    Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
    Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC8 inhibition ameliorates pulmonary fibrosis.
    Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.
    Huang SK; Scruggs AM; Donaghy J; Horowitz JC; Zaslona Z; Przybranowski S; White ES; Peters-Golden M
    Cell Death Dis; 2013 May; 4(5):e621. PubMed ID: 23640463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
    Hyndman KA
    Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase: a potential therapeutic target for fibrotic disorders.
    Pang M; Zhuang S
    J Pharmacol Exp Ther; 2010 Nov; 335(2):266-72. PubMed ID: 20719940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
    Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
    Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention.
    Ganai SA
    Curr Drug Targets; 2018; 19(6):593-601. PubMed ID: 27231104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.
    Joanna F; van Grunsven LA; Mathieu V; Sarah S; Sarah D; Karin V; Tamara V; Vera R
    J Cell Mol Med; 2009 Sep; 13(9B):2990-3005. PubMed ID: 19583816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
    Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
    Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.